Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia

被引:29
|
作者
Phung Anh Nguyen [1 ]
Islam, Mohaimenul [1 ,2 ]
Galvin, Cooper J. [1 ]
Chang, Chih-Cheng [3 ,4 ]
An, Soo Yeon [5 ]
Yang, Hsuan-Chia [4 ]
Huang, Chih-Wei [1 ]
Li, Yu-Chuan [1 ,4 ,6 ]
Iqbal, Usman [1 ,7 ]
机构
[1] Taipei Med Univ, Coll Med Sci & Technol, Int Ctr Hlth Informat Technol, Taipei 11031, Taiwan
[2] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei 11031, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei 235, Taiwan
[4] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan
[5] Chungnam Natl Univ Hosp, Dept Cardiol, Daejeon 35015, South Korea
[6] Wan Fang Hosp, Dept Dermatol, Taipei 116, Taiwan
[7] Taipei Med Univ, Coll Publ Hlth, Global Hlth & Dev Dept, Global Hlth & Hlth Secur, Taipei 11031, Taiwan
关键词
clinical study; epidemiology; gastrointestinal diseases; pneumonia; proton pump inhibitors; OBSTRUCTIVE PULMONARY-DISEASE; STRESS-ULCER; ADULTS; HOSPITALIZATION; PREVENTION; MANAGEMENT; DIAGNOSIS; THERAPY;
D O I
10.1093/intqhc/mzaa041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Proton pump inhibitors (PPIs), one of the most widely used medications, are commonly used to suppress several acid-related upper gastrointestinal disorders. Acid-suppressing medication use could be associated with increased risk of community-acquired pneumonia (CAP), although the results of clinical studies have been conflicting. Data sources: A comprehensive search of MEDLINE, EMBASE and Cochrane library and Database of Systematic Reviews from the earliest available online year of indexing up to October 2018. Study selection: We performed a systematic review and meta-analysis of observational studies to evaluate the risk of PPI use on CAP outcomes. Data extraction: Included study location, design, population, the prevalence of CAP, comparison group and other confounders. We calculated pooled odds ratio (OR) using a random-effects meta-analysis. Results of data synthesis: Of the 2577 studies screening, 11 papers were included in the systematic review and 7 studies with 65 590 CAP cases were included in the random-effects meta-analysis. In current PPI users, pooled OR for CAP was 1.86 (95% confidence interval (CI), 1.30-2.66), and in the case of recent users, OR for CAP was 1.66 (95% CI, 1.22-2.25). In the subgroup analysis of CAP, significance association is also observed in both high-dose and low-dose PPI therapy. When stratified by duration of exposure, 3-6 months PPIs users group was associated with increased risk of developing CAP (OR, 2.05; 95% CI, 1.22-3.45). There was a statistically significant association between the PPI users and the rate of hospitalization (OR, 2.59; 95% CI, 1.83-3.66). Conclusion: We found possible evidence linking PPI use to an increased risk of CAP. More randomized controlled studies are warranted to clarify an understanding of the association between PPI use and risk of CAP because observational studies cannot clarify whether the observed epidemiologic association is a causal effect or a result of unmeasured/residual confounding.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [41] Use of ACE inhibitors and risk of community-acquired pneumonia: a review
    Rafailidis, Petros I.
    Matthaiou, Dimitrios K.
    Varbobitis, Ioannis
    Falagas, Matthew E.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (06) : 565 - 573
  • [42] Use of proton pump inhibitors and the risk of community acquired pneumonia: A Populationbased case control study
    Gulmez, Sinem Ezgi
    Holm, Anette
    Frederiksen, Henrik
    Jensen, Thoger Gorm
    Pedersen, Court
    Hallas, Jesper
    EURASIAN JOURNAL OF PULMONOLOGY, 2008, 10 (03) : 177 - 183
  • [43] Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
    Hussain, Salman
    Singh, Ambrish
    Antony, Benny
    Klugarova, Jitka
    Murad, M. Hassan
    Jayraj, Aarthi S.
    Langaufova, Alena
    Klugar, Miloslav
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [44] Proton Pump Inhibitors and the Risk of Colorectal Cancer: A Meta-analysis
    Chen, Shicai
    Song, Xinming
    Gao, Xiang
    Li, Mingzhe
    Chen, Zhihui
    He, Yulong
    Zhan, Wenhua
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (02) : 177 - 177
  • [45] Use of ACE inhibitors and risk of community-acquired pneumonia: a review
    Petros I. Rafailidis
    Dimitrios K. Matthaiou
    Ioannis Varbobitis
    Matthew E. Falagas
    European Journal of Clinical Pharmacology, 2008, 64 : 565 - 573
  • [46] Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia
    de Jager, C. P. C.
    Wever, P. C.
    Gemen, E. F. A.
    van Oijen, M. G. H.
    van Gageldonk-Lafeber, A. B.
    Siersema, P. D.
    Kusters, G. C. M.
    Laheij, R. J. F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (10) : 941 - 949
  • [47] Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis
    Marchello, Christian
    Dale, Ariella Perry
    Thuy Nhu Thai
    Han, Duk Soo
    Ebell, Mark H.
    ANNALS OF FAMILY MEDICINE, 2016, 14 (06) : 552 - 566
  • [48] The benefits of non-invasive ventilation for community-acquired pneumonia: a meta-analysis
    Klefti, G.
    Hill, A. T.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2022, 115 (07) : 429 - 435
  • [49] Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia A meta-analysis
    Jiang, Shan
    Liu, Tiecheng
    Hu, Yuxin
    Li, Ranwei
    Di, Xin
    Jin, Xin
    Wang, Yanqiao
    Wang, Ke
    MEDICINE, 2019, 98 (26)
  • [50] Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials
    Yuan, Xin
    Liang, Bei-Bei
    Wang, Rui
    Liu, You-Ning
    Sun, Chun-Guang
    Cai, Yun
    Yu, Xu-Hong
    Bai, Nan
    Zhao, Tie-Mei
    Cui, Jun-Chang
    Chen, Liang-An
    JOURNAL OF CHEMOTHERAPY, 2012, 24 (05) : 257 - 267